Toxic megacolon medical therapy
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]
Overview
Overview
Medical therapy of toxic megacolon include stablizing the patient, decompression and medications. Medications for toxic megacolon include corticosteroids, immunosuppresants and antibiotics.
Medical Therapy
Medical Therapy
Medical therapy of Toxic megacolon include:[1][2][3][4][5][6]
- 1. General considerations
- 1.1. Complete bowel rest
- 1.2. Intravenous fluid support
- 1.3. Electrocytes monitoring and correction of abnormalities
- 1.4. Withdrawal of all anticholinergics, antidiarrheal and narcotics
- 1.5. Rule out infectious etiology
- 2. Decompression
- 2.1. Rectal tube
- 2.2. Nasogastric or long naso-intestinal tube
- Note: Long intestinal tubes are considered to be more effective than naso-gastric tubes in colonic decompression but should be placed into the ileum under fluoroscopic guidance.
- Note: Maneuver 1: Asking patients to roll into the prone position for 10-15 minutes every 2-3 hours and encourage them to pass gas.
- Note: Maneuver 2: Turning to the prone knee-elbow position, which moves the rectum to the highest point in the body.
- 3. Medical management
- 3.1. Toxic megacolon associated with inflammatory bowel disease(IBD):[1][9]
- 3.1.1. Corticosteroids:
- Preferred regimen (1): Hydrocortisone 100 mg IV q6h
- Preferred regimen (2): Methylprednisolone 60 mg IV q24h
- 3.1.2. Immunosuppresants:
- Preferred regimen (1): Cyclosporin 2 mg/kg q24h for 7 days
- Note: Maintain serum levels between 150 to 250 ng/mL
- Preferred regimen (2): Infliximab 5 mg/kg for 3 to 7 days
- 3.1.1. Corticosteroids:
- 3.2. Toxic megacolon associated with Clostridium difficile [10]
- Preferred regimen (1): Vancomycin 500 mg PO q6h or via a naso-gastric tube AND Metronidazole 500 mg IV q8h
- 3.1. Toxic megacolon associated with inflammatory bowel disease(IBD):[1][9]
References
References
- ↑ 1.0 1.1 Gan, S. Ian; Beck, P. L. (2003). “A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management”. The American Journal of Gastroenterology. 98 (11): 2363–2371. doi:10.1111/j.1572-0241.2003.07696.x. ISSN 0002-9270.
- ↑ Autenrieth DM, Baumgart DC (2012). “Toxic megacolon”. Inflamm. Bowel Dis. 18 (3): 584–91. doi:10.1002/ibd.21847. PMID 22009735.
- ↑ Farkouh E, Wassef R, Allard M, Atlas H (1983). “Toxic megacolon in inflammatory colon disease”. Union Med Can (in French). 112 (11): 1014–6. PMID 6665937.
- ↑ Gonzáles Lara V, Pérez Calle JL, Marín Jiménez I (2003). “Approach to toxic megacolon”. Rev Esp Enferm Dig. 95 (6): 422–8, 415–21. PMID 12918536.
- ↑ Koudahl G, Kristensen M (1975). “Toxic megacolon in ulcerative colitis”. Scand. J. Gastroenterol. 10 (4): 417–21. PMID 1153934.
- ↑ Meyers S, Janowitz HD (1978). “The place of steroids in the therapy of toxic megacolon”. Gastroenterology. 75 (4): 729–31. PMID 213344.
- ↑ Present DH, Wolfson D, Gelernt IM, Rubin PH, Bauer J, Chapman ML (1988). “Medical decompression of toxic megacolon by “rolling”. A new technique of decompression with favorable long-term follow-up”. J. Clin. Gastroenterol. 10 (5): 485–90. PMID 3183326.
- ↑ Panos MZ, Wood MJ, Asquith P (1993). “Toxic megacolon: the knee-elbow position relieves bowel distension”. Gut. 34 (12): 1726–7. PMC 1374472. PMID 8282262.
- ↑ Strong SA (2010). “Management of acute colitis and toxic megacolon”. Clin Colon Rectal Surg. 23 (4): 274–84. doi:10.1055/s-0030-1268254. PMC 3134807. PMID 22131898.
- ↑ Bolton RP, Culshaw MA (1986). “Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile”. Gut. 27 (10): 1169–72. PMC 1433873. PMID 3781329.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
